In Reply We were gratified at the interest generated about our article on the treatment of nonmelanoma skin cancer (NMSC),1 as evidenced by 3 Letters to the Editor and more than 100 emails to the senior author. As is the case for most articles, what was read and understood was dependent on the perspective of the person reading it. Our goal was to provide data with which to counsel patients and to provide the basis for a discussion for treating specialists.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Tholpady SS, Cohen AC, Chu MW. Age and Treatment of Nonmelanoma Skin Cancer—Reply. JAMA Surg. 2018;153(9):867–868. doi:10.1001/jamasurg.2018.1697
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: